Presentation
17 March 2023 Impact of tumor microenvironment in antibody-HER2 binding using macroscopy fluorescence lifetime FRET in vivo imaging
Amit Verma, Vikas Pandey, Jason T. Smith, Xavier Intes, Margarida Barroso
Author Affiliations +
Abstract
Our goal is to accelerate pre-clinical drug discovery by developing novel imaging assays to screen and optimize the delivery of targeted anti-cancer drugs. Fluorescence lifetime imaging (FLI) Forster Resonance Energy Transfer (FRET) acts as a direct reporter of drug-target engagement in live mice carrying HER2-overexpressing tumor xenografts. We have established near-infrared (NIR) Macroscopy FLI FRET (MFLI-FRET) non-invasive imaging approach to measure drug-target engagement in deep tissues. We used trastuzumab (TZM), an anti-HER2 antibody clinical drug, as NIR-labeled FRET probes to assess quantitatively the role of tumor microenvironment on drug-target binding and penetration in tumor xenografts.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Amit Verma, Vikas Pandey, Jason T. Smith, Xavier Intes, and Margarida Barroso "Impact of tumor microenvironment in antibody-HER2 binding using macroscopy fluorescence lifetime FRET in vivo imaging", Proc. SPIE 12357, Visualizing and Quantifying Drug Distribution in Tissue VII, 123570D (17 March 2023); https://doi.org/10.1117/12.2650382
Advertisement
Advertisement
KEYWORDS
Tumors

Fluorescence resonance energy transfer

In vivo imaging

Luminescence

Collagen

Multiplexing

Near infrared

Back to Top